Borderline Resectable Pancreatic Ductal Adenocarcinoma Clinical Trials in Atlanta, Georgia
2 recruitingAtlanta, Georgia
Showing 1–2 of 2 trials
Recruiting
Phase 2
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
Stage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Resectable Pancreatic Adenocarcinoma+2 more
Emory University36 enrolled1 locationNCT06423326
Recruiting
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
Borderline Resectable Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8Resectable Pancreatic Ductal Adenocarcinoma
Emory University87 enrolled1 locationNCT06595160